Webinar replay

Investing in Global Health Security: Overcoming Challenges in Antibiotic Development

This panel will highlight research and collaborations to develop new tools to tackle AMR and provide an update on efforts to facilitate development and uptake of innovation. While these tools may be years from approval, policy engagement to address identified barriers must begin now.

Watch this replay to get expert insights from our panelists:
Gregory Frank_BIO
Gregory Frank
PhD, Senior Director, Infectious Disease Policy
BIO
Avatar
Pierre Daram
Global Project Leader, Associate Director Portfolio Management
Debiopharm
silas_holland_400x400
Silas Holland
Head of External Affairs (Interim)
AMR Action Fund
Jeremy Knox_WellcomeTrust
Jeremy Knox
Policy and Advocacy Lead, Drug Resistant Infections Programme
Wellcome Trust
Karolina Puskarczyk_Pfizer
Karolina Puskarczyk
Senior Manager, Innovation Policy
Pfizer

Watch the recording

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 150 life science companies, including 50% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.